-
Short Seller's Bombshell Report Rattles Grifols: Stock Chart Points To Potential Further Decline
Tuesday, January 9, 2024 - 2:09pm | 1217Read More...Grifols S.A. (NASDAQ:GRFS), the Barcelona, Spain-based pharmaceutical company, saw its shares plummet by 24% on Tuesday. This marked the company’s most significant single-day drop since its initial public offering. The cause? A bombshell short report released by Gotham City Research that...
-
COVID-19 Convalescent Plasma Study Shows No Benefit, US NIH Stops Trial
Wednesday, March 3, 2021 - 6:20am | 284Read More...The National Institutes of Health (NIH) has halted a trial evaluating the safety and effectiveness of COVID-19 convalescent plasma in treating emergency department patients with mild to moderate symptoms. This move comes less than two months after an international trial of convalescent...
-
Takeda-Led Group Begins Manufacturing COVID-19 Plasma Treatment, Says Confident Of Efficacy
Tuesday, October 13, 2020 - 2:32am | 364Read More...A group led by Takeda Pharmaceutical Company Limited (NYSE: TAK) has begun manufacturing a blood plasma treatment for COVID-19, even as late-stage human testing remains pending, the company’s CEO Christophe Weber told Reuters Monday. What Happened: The CoVIg Plasma Alliance, composed of...
